This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

India-EU FTA to force high-speed overhaul of Indian patent law

By Freny Patel ( January 29, 2026, 00:55 GMT | Comment) -- The India-EU Free Trade Agreement pressures India to strengthen the protection of intellectual property to attract investment, while testing its ability to balance innovation, public health priorities and its role as the world’s generic medicine supplier.The newly finalized India-EU Free Trade Agreement — hailed by officials as the “mother of all deals” — is set to do far more than slash duties on luxury cars and fine wines. The pact is widely seen as a compulsory catalyst for a sweeping overhaul of India’s intellectual property framework, potentially ending an era of judicial leniency toward the country’s powerful generic pharmaceutical lobby....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections